MedPath

Study for Perioperative Neurocognitive Disorders After Deep Brain Stimulation Surgery for Parkinson's Disease

Conditions
Neurocognitive Disorders
Registration Number
NCT04696978
Lead Sponsor
wenbinlu
Brief Summary

Perioperative neurocognitive disorders(PND) is common to see in elderly patients. Although PND increases patient mortality as well as hospitalization time, apparent inflammatory factors, and related mechanisms are still unknown. Metabolites could reveal chemical fingerprints left behind by cellular processes, which in turn provide a new aspect to understand the biological process behind. we aim to found the metabolomics can aid the development of diagnostic markers of PND screening, early detection, and further, provide a basis for disease prevention and treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Parkinson's patients undergoing elective deep brain stimulation
  • Age ≥55 years
  • ASA physical statusⅠ-Ⅲ
  • Elementary school or above
Exclusion Criteria
  • patients with ASA physical status>III
  • patients with systemic immune diseases, hematological diseases (hematological tumors or leukemia), patients after transplantation, malignant tumors
  • patients with metabolic diseases such as diabetes, ketoacidosis, hyperosmolar syndrome, long-term hypoglycemia,gout
  • patients who refused to join the study and lost to follow-up

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the level of metabolomics in patients' blood sample72 hours after operation
Secondary Outcome Measures
NameTimeMethod
CAM-ICU score1 month after operation

Trial Locations

Locations (1)

Changhai Hospital, Second Military Medical University

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath